Navigation Links
Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009
Date:10/8/2009

CHADDS FORD, Pa., Oct. 8 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) will announce its third quarter financial results on October 29, 2009 and will host a conference call and webcast at 9:00 a.m. ET that day to discuss these results.

David P. Holveck, president and chief executive officer, Ivan Gergel, M.D., executive vice president of research and development, Alan Levin, chief financial officer and Blaine Davis, vice president, corporate affairs will host the call.

Investors and other interested parties may call 800-798-2884 (domestic) or 617-614-6207 (international) and enter passcode 12555118. Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from October 29 at 12:00 p.m. ET until 12:00 a.m. ET on November 4 by dialing 888-286-8010 (domestic) or 617-801-6888 (international) and entering passcode 66458151.

A simultaneous webcast of the call may be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 12:00 a.m. ET on November 4. The replay can be accessed by clicking on "Upcoming Events" in the Investor Relations section of the website.

About Endo

Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, overactive bladder, prostate cancer and the early onset of puberty in children, or central precocious puberty (CPP). Its products include LIDODERM®, a topical patch to relieve the pain of postherpetic neuralgia; Percocet® and Percodan® tablets for the relief of moderate-to-moderately severe pain; FROVA® tablets for the acute treatment of migraine attacks with or
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3
2. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry
5. Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray
6. Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
7. Tetraphase Pharmaceuticals Completes Series B Financing to Support the Advancement of Novel Antibiotic Drug Candidates
8. Merz Pharmaceuticals Announces Phase III Data for NT 201 in Post-stroke Upper Limb Spasticity
9. Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM)
10. Conatus Pharmaceuticals to Present at the Montgomery Healthcare Conference
11. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...wire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin B...nown as DOR BioPharma, Inc., a late-stage biotechn...a consortium to develop thermostable technology to...es. Soligenix received a $9.4 million grant from t...seases (NIAID), a division of the National Institu...
(Date:11/19/2009)...wire-FirstCall/ -- In a series of new initiatives ...ation (Nasdaq: HSKA ) ("Heska" or the "Company") ... website. The upgraded site is the result of seve...align the site with the company,s new brand image ...ww.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,...
(Date:11/19/2009)...swire-FirstCall/ -- The D e al magazine has na...ed Corporate Dealmakers for the second consecutive...red Dealmaker in pharma/biotech for the most effec...s since January 2006. ,, Over the past decade, ...focus on high-growth, innovation-driven businesses...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3New Mexico School Boards Association and Accelify Announce Alliance to Assist New Mexico Schools 54497 1New Mexico School Boards Association and Accelify Announce Alliance to Assist New Mexico Schools 54497 2Compound Targets Destroys Cancer Stem Cells in Mice 54494 1Compound Targets Destroys Cancer Stem Cells in Mice 54494 2Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 1Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 2Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 3Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 4Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 5Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 6Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 7Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 8Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results 54490 9
... 2008 Annual Financial Guidance, DUBLIN, Calif., ...ical company dedicated to the discovery, rapid,dev...lid tumors and,hematological malignancies, today c...rial, initiated in 2002, comparing Dacogen(R) (dec...C) in elderly patients with,myelodysplastic syndro...
... July 1 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX...ts from its,discontinued Phase 3 clinical trial of...biomodulator of 5-FU (5 fluorouracil), for the tre... The primary endpoint of the study,was progression... reported,by the Company along with safety data la...
Other Medicine Technology:SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 2SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 3SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 4ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R) 2ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R) 3ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R) 4
(Date:11/22/2009)... under control, expert says , , SUNDAY, ...ns you,ll be faced with a seemingly endless buffet... in and eat too much, others deny themselves any h... between overindulgence and deprivation, according...rvices at Brigham and Women,s Hospital in Boston. ...
(Date:11/21/2009)...Newswire-USNewswire/ -- Tonight, in a partisan vot...d,s version of the government takeover of health c...d in this bill; like the public option, employer a...for elective abortion, which is the most onerous a...ovides subsidies for private plans that cover elec...
(Date:11/21/2009)...Key Provisions of Legislation, Continues Push for ... Ill., Nov. 21 With t...ark Affordable Health Care for America Act (H.R. 3...slation forward, Congress has taken decisive steps...oday, AARP hosted an educational forum to discuss ...
(Date:11/21/2009)...all, president and chief executive officer of the ... following statement regarding the inclusion of co...nual wellness for Medicare beneficiaries in "...t; that was introduced last night: , ... -- Eric J. Hall, president and chief executive of...
(Date:11/20/2009)...RNewswire-USNewswire/ -- The American Academy of ...are reform legislation released this week to conta...individual coverage mandate. The actuaries said th...ize adverse selection stemming from more restricti...,, "The individual mandate language should be s...
Breaking Medicine News(10 mins):Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Actuaries to Senate: Strengthen Individual Mandate 2
... cholesterol drug no better than placebo at easing... , MONDAY, July 21 (HealthDay News) -- The con... the risk of major heart valve problems, according... was no better than placebo at lowering the odds o...
...University, the University of Cincinnati (UC) and ...are hoping to find a geographical pattern to help ...fatal neurological disease amyotrophic lateral scl...e,ve found there were some areas of service where ...
...ple have consumed cranberry juice, convinced of it...gh the exact mechanism of its action has not been ...cester Polytechnic Institute (WPI) reveals that th...g close enough to latch onto cells and initiate an...
...ls on organ,s surface, spare surrounding tissue ...tients are being recruited for a clinical trial of...l for pleural mesothelioma, a cancer of the lung,s...nd chemotherapy treatments of patients with malign...
...nopause women think that only hormones can reduce ...ol herbs can cool down hot flashes not only effect...Ann Arbor, MI (PRWEB) July 21, 2008 -- The hot sum...plicated information overwhelms menopause women. S...
...p in understanding how the nervous system and the ...n Institute for Medical Research have identified a...he spleen communicate. , ...stein Institute for Medical Research have identif...
Other Medicine News:Health News:Vytorin Fails to Lower Heart Valve Problems 2Health News:Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans 2Health News:Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans 3Health News:Cranberry juice creates energy barrier that keeps bacteria away from cells, study shows 2Health News:Lung Cancer Trial Targets Asbestos-Related Disease 2Health News:Menopause: Hot Flashes Can Be Reduced 90% without Hormones 2Health News:Menopause: Hot Flashes Can Be Reduced 90% without Hormones 3Health News:Embargoed Until Monday, July 21 at 5 p.m. EST; Scientists Figure Out How the Immune System and Brain Communicate to Control Disease 2Health News:Embargoed Until Monday, July 21 at 5 p.m. EST; Scientists Figure Out How the Immune System and Brain Communicate to Control Disease 3
MiniCycler thermal cycler
Dual-bay Dyad thermal cycler chassis
... with 24-well x 0.2ml sub-ambient block and automa...rmistor) Heating rates: up to 3C/second; Accurate ...om 4-99C; Excellent uniformity: better than 0.5C w...programming: directory program storage of up to 60...
...ycler unit is an inexpensive personal or mini ther...ess. Lightweight, with a small footprint, it can b...luding the researcher's desk. , The Gene Cycl...ho do not have access to a large laboratory therma...
Medicine Products: